Mark Baillie, Ph.D.
Institution:
Emory University, Atlanta, GAArea:
Medicinal, Bioorganic, Synthetic Organic, ComputationalGoogle:
"Mark Baillie"Mean distance: 9.82 | S | N | B | C | P |
Parents
Sign in to add mentor| Dennis C. Liotta | grad student | 2011 | Emory | |
| (Towards the Development of Non-Toxic Therapeutics in the Fight Against Cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Miller EJ, Mays SG, Baillie MT, et al. (2016) Discovery of a Fluorinated Enigmol Analog with Enhanced in Vivo Pharmacokinetic and Anti-Tumor Properties. Acs Medicinal Chemistry Letters. 7: 537-42 |
| Mays SG, Baillie MT, Miller EJ, et al. (2013) 330 FLUORINATION OF ENIGMOL IMPROVES TISSUE UPTAKE AND AFFECTS IN VIVO PROSTATE CANCER EFFICACY Journal of Urology. 189 |
| Garnier-Amblard EC, Mays SG, Arrendale RF, et al. (2011) Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer. Acs Medicinal Chemistry Letters. 2: 438-43 |
| Garnier-Amblard EC, Mays SG, Arrendale RF, et al. (2011) Novel synthesis and biological evaluation of enigmols as therapeutic agents for treating prostate cancer Acs Medicinal Chemistry Letters. 2: 438-443 |